DRRX

DRRX

USD

DURECT Corporation Common Stock

$1.910-0.020 (-1.036%)

Echtzeitkurs

Healthcare
Drug Manufacturers - Specialty & Generic
Vereinigte Staaten

Kursdiagramm

Keine Diagrammdaten verfügbar

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.930

Hoch

$1.910

Tief

$1.910

Volumen

N/A

Unternehmensfundamentaldaten

Marktkapitalisierung

59.3M

Branche

Drug Manufacturers - Specialty & Generic

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.36M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.4801Aktuell $1.910Hoch $2.64

Ähnliche Nachrichten

AccessWire

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. , a global, diversified pharmaceutical company, and DURECT Corporation today announced that

Mehr anzeigen
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mehr anzeigen
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders
PR Newswire

DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the second quarter ended June 30, 2025 and provided an update on the...

Mehr anzeigen
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health